Validation of the rat model of cryptogenic infantile spasms

Epilepsia

Volumn 52, Issue 9, 2011, Pages 1666-1677

  Chachua, Tamar ^a,c   Yum, Mi Sun ^a,d   Velíšková, Jana ^a,b,c   Velíšek, Libor ^a,b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d Asan Medical Center   (South Korea)

Author keywords

ACTH; Behavior; Clustering; EEG; Methylprednisolone; Spasms; Vigabatrin

Indexed keywords

BETAMETHASONE; CORTICOTROPIN; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID; RAPAMYCIN; VIGABATRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; FEMALE; GESTATIONAL AGE; HYPSARRHYTHMIA; INFANTILE SPASM; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PREMEDICATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; VALIDATION PROCESS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANIMALS, NEWBORN; BETAMETHASONE; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EXPLORATORY BEHAVIOR; FEMALE; GABA AGENTS; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; MALE; MAZE LEARNING; METHYLPREDNISOLONE; N-METHYLASPARTATE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; SPASMS, INFANTILE; TIME FACTORS; VIGABATRIN;

EID: 80052550273     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2011.03220.x     Document Type: Article

References (40)

1. Avishai-Eliner S, Brunson KL, Sandman CA, Baram TZ,. (2002) Stressed-out, or in (utero)? Trends Neurosci 25: 518-524. (Pubitemid 35246322)
2. Baram TZ,. (2001) What are the reasons for the strikingly different approaches to the use of ACTH in infants with West syndrome? Brain Dev 23: 647-648. (Pubitemid 32999141)
3. Baram TZ,. (2003) Treatment of infantile spasms: the ideal and the mundane. Epilepsia 44: 993-994. (Pubitemid 36959303)
4. Baram TZ, Mitchell WG, Tournay A, Snead OC, Hanson RA, Horton EJ,. (1996) High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 97: 375-379. (Pubitemid 26076265)
5. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshe SL, Nordli D, Plouin P, Scheffer IE,. (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51: 676-685.
6. Brunson KL, Avishai-Eliner S, Baram TZ,. (2002) ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 49: 185-197.
7. Committee for the Update of the Guide for the Care and Use of Laboratory Animals. (2011) Guide for the Care and Use of Laboratory Animals. The National Academies Press, Washington, D.C.
8. Dulac O,. (1994) Infantile spasms and West syndrome. W. B. Saunders, London.
9. Dulac O, Soufflet C, Chiron C, Kaminska A,. (2002) What is West syndrome? Int Rev Neurobiol 49: 1-22.
10. Elterman RD, Shields WD, Bittman RM, Torri SA, Sagar SM, Collins SD,. (2010) Vigabatrin for the treatment of infantile spasms: final report of a randomized trial. J Child Neurol 25: 1340-1347.
11. Gallagher JP, Orozco-Cabal LF, Liu J, Shinnick-Gallagher P,. (2008) Synaptic physiology of central CRH system. Eur J Pharmacol 583: 215-225.
12. Gottlieb A, Keydar I, Epstein HT,. (1977) Rodent brain growth stages: an analytical review. Biol Neonate 32: 166-176. (Pubitemid 8265776)
13. Hrachovy RA, Frost JD Jr,. (2003) Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome). J Clin Neurophysiol 20: 408-425. (Pubitemid 38133969)
14. Kábová R, Liptáková S, Å lamberová R, Pometlová M, Velíšek L,. (1999) Age-specific N-methyl-D-aspartate-induced seizures: perspectives for the West syndrome model. Epilepsia 40: 1357-1369. (Pubitemid 29471334)
15. Kellaway P, Frost JD, Hrachovy RA,. (1983) Infantile spasms. In, Morselli PL, Pippenger CE, Penry JK, (Eds) Antiepileptic drug therapy in pediatrics. Raven Press, New York, pp. 115-136.
16. Kubová H, Mareš P,. (2010) Vigabatrin but not valproate prevents development of age-specific flexion seizures induced by N-methyl-D-aspartate (NMDA) in immature rats. Epilepsia 51: 469-472.
17. Kuzmiski JB, Marty V, Baimoukhametova DV, Bains JS,. (2010) Stress-induced priming of glutamate synapses unmasks associative short-term plasticity. Nat Neurosci 13: 1257-1264.
18. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP,. (2004) The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 364: 1773-1778. (Pubitemid 39488062)
19. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP,. (2005) The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 4: 712-717. (Pubitemid 41457286)
20. Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, Baram TZ, Duchowny M, Hirtz D, Pellock JM, Shields WD, Shinnar S, Wyllie E, Snead OC III,. (2004) Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 62: 1668-1681. (Pubitemid 38661719)
21. Mori H, Inoki K, Munzberg H, Opland D, Faouzi M, Villanueva EC, Ikenoue T, Kwiatkowski D, MacDougald OA, Myers MG Jr, Guan KL,. (2009) Critical role for hypothalamic mTOR activity in energy balance. Cell Metab 9: 362-374.
22. Muncy J, Butler IJ, Koenig MK,. (2009) Rapamycin reduces seizure frequency in tuberous sclerosis complex. J Child Neurol 24: 477.
23. Pellow S, File SE,. (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24: 525-529. (Pubitemid 16145187)
24. Pellow S, Chopin P, File SE, Briley M,. (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14: 149-167. (Pubitemid 16239568)
25. Pitkanen A, Lukasiuk K,. (2011) Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 10: 173-186.
26. Riikonen R,. (2001) Long-term outcome of patients with West syndrome. Brain Dev 23: 683-687. (Pubitemid 32999148)
27. Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, Markhard AL, Sabatini DM,. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22: 159-168.
28. Scantlebury MH, Galanopoulou AS, Chudomelova L, Raffo E, Betancourth D, Moshe SL,. (2010) A model of symptomatic infantile spasms syndrome. Neurobiol Dis 37: 604-612.
29. Shang NX, Zou LP, Zhao JB, Zhang F, Li H,. (2010) Association between prenatal stress and infantile spasms: a case-control study in China. Pediatr Neurol 42: 181-186.
30. Stafstrom CE,. (2009) Infantile spasms: a critical review of emerging animal models. Epilepsy Curr 9: 75-81.
31. Stafstrom CE, Holmes GL,. (2002) Infantile spasms: criteria for an animal model. Int Rev Neurobiol 49: 391-411.
32. Stafstrom CE, Sasaki-Adams DM,. (2003) NMDA-induced seizures in developing rats cause long-term learning impairment and increased seizure susceptibility. Epilepsy Res 53: 129-137. (Pubitemid 36170176)
33. Stafstrom CE, Moshé SL, Swann JW, Nehlig A, Jacobs MP, Schwartzkroin PA,. (2006) Models of pediatric epilepsies: strategies and opportunities. Epilepsia 47: 1407-1414. (Pubitemid 44200424)
34. Tolman JA, Faulkner MA,. (2009) Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval. Expert Opin Pharmacother 10: 3077-3089.
35. Velíšek L,. (2006) Prenatal exposure to betamethasone decreases anxiety in developing rats: hippocampal neuropeptide Y as a target molecule. Neuropsychopharmacology 31: 2140-2149. (Pubitemid 44413191)
36. Velíšek L, Moshé SL,. (2002) Effects of brief seizures during development. In, Sutula T, Pitkanen A, (Eds) Do seizures damage the brain. Elsevier, Amsterdam, pp. 355-364. (Pubitemid 35461031)
37. Velíšek L, Velíšková J, Ptachewich Y, Ortíz J, Shinnar S, Moshé SL,. (1995) Age-dependent effects of gamma-aminobutyric acid agents on flurothyl seizures. Epilepsia 36: 636-643.
38. Velíšek L, Jehle K, Asche S, Velíšková J,. (2007) Model of infantile spasms induced by N-methyl-D-aspartic acid in prenatally impaired brain. Ann Neurol 61: 109-119. (Pubitemid 46363838)
39. Velíšek L, Chachua T, Yum MS, Poon KL, Velíš ková J,. (2010) Model of cryptogenic infantile spasms after prenatal corticosteroid priming. Epilepsia 51 (Suppl. 3): 145-149.
40. Zupanc ML,. (2003) Infantile spasms. Expert Opin Pharmacother 4: 2039-2048. (Pubitemid 37408115)